Plain English summary
G lue ear (also known as otitis media with effusion) is a condition in which fluid builds up behind the ear drum. It is very common in children and is the most common reason for children to have bad hearing. Most cases of glue ear get better with time, but some children have bad hearing from glue ear for many months, and this can affect learning, behaviour, language and mood. Very few treatments have been found to help glue ear. Many children have an operation (grommet surgery), but this involves a general anaesthetic and sometimes only works for a short period of time. Steroid tablets are often used to treat conditions such as asthma in children. Some studies have found that steroids may help glue ear to get better, but previous studies gave different results and were not of good quality.
The Oral STeroids for the Resolution of otitis media with effusion In CHildren (OSTRICH) trial set out to see if steroid tablets would help improve hearing in children with glue ear, in both ears, who have had this for 3 months or more, as well as proven hearing loss. Children were given steroid tablets or dummy (placebo) tablets for 1 week and had their hearing assessed 4 weeks after treatment, and again after 6 and 12 months. Around one in three children had good hearing 4 weeks after treatment and this had increased to around half of the children after 6 months. Slightly more children who had been given steroids developed good hearing, but the difference was small and could be because of chance. We found no differences between groups in symptoms, grommet operations, number of visits to the doctor or quality of life.
These findings suggest that lots of children with glue ear that has lasted 3 months or longer will get better with time, and that taking steroid tablets does not help hearing to get better more quickly.
HTA programme
The HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.
The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC) policy decisions.
For more information about the HTA programme please visit the website: http://www.nets.nihr.ac.uk/programmes/hta
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